Home・Akciju saraksts・Collegium Pharmaceutical Inc

C
Collegium Pharmaceutical Inc

Atvērts

SektorsVeselības aprūpe

28.12 0.68

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

26.93

Max

28.33

Galvenie mērījumi
By Trading Economics
Ienākumi	-30M -15M
Pārdošana	6.4M 200M
P/E Sektora vidējais	21.417 57.002
EPS	1.57
Peļņas marža	-7.53
Darbinieki	423
EBITDA	-20M 71M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+82.06% upside

Dividendes
By Acuity
Nākamie ieņēmumi	2026. g. 5. nov.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-272M 882M
Iepriekšējā atvēršanas cena	27.44
Iepriekšējā slēgšanas cena	28.12

Ziņu noskaņojums

By Acuity

43%

57%

150 / 340 Rangs Healthcare

Collegium Pharmaceutical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 13. aug. 22:51 UTC

Collegium Pharmaceutical Inc shares rose in after-market trading, reflecting broader market gains amid unchanged producer prices and easing inflation expectations.

2026. g. 12. aug. 19:51 UTC

Collegium Pharmaceutical Inc's shares are lower today, continuing a trend of recent weakness amid unusually high market volume. No specific news was identified.

2026. g. 11. aug. 22:01 UTC

Collegium Pharmaceutical Inc shares are higher in after-market trading, reversing earlier session dips and showing strength after three consecutive lower closes.

2026. g. 10. aug. 21:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a trend since Monday's close, and are significantly below their 20-day moving average.

2026. g. 7. aug. 21:01 UTC

Collegium Pharmaceutical Inc shares are trading higher in after-market hours. No specific news was identified to explain the movement.

2026. g. 6. aug. 23:11 UTC

Collegium Pharmaceutical Inc shares are higher in after-market hours, recovering from an initial dip but remain below their 20-day moving average.

2026. g. 4. aug. 19:26 UTC

Collegium Pharmaceutical Inc shares are lower today, trading near the lower end of their one-month range, with no specific news driving the decline.

2026. g. 3. aug. 19:46 UTC

Collegium Pharmaceutical Inc is trading lower today, continuing a three-session decline. The stock peaked early but has since pulled back.

2026. g. 31. jūl. 20:06 UTC

News

Collegium Pharmaceutical is under scrutiny due to concerns over its financial performance, contributing to a decline in shares during Friday's session.

2026. g. 30. jūl. 20:09 UTC

Collegium Pharmaceutical Inc shares are lower in Thursday's session, with no specific news to explain the decline amid broader market volatility.

2026. g. 29. jūl. 22:01 UTC

Collegium Pharmaceutical Inc is trading higher in after-market hours, continuing a positive trend with gains over four consecutive sessions amid cautious investor sentiment.

2026. g. 28. jūl. 22:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressures, particularly in Asia.

2026. g. 27. jūl. 19:07 UTC

News

Collegium Pharmaceutical reported first-quarter revenues of $193.5 million, surpassing expectations, while shares are trading higher amid broader strength in the pharmaceutical sector.

2026. g. 24. jūl. 19:46 UTC

Collegium Pharmaceutical Inc shares are lower during Friday's session, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

2026. g. 22. jūl. 20:01 UTC

Collegium Pharmaceutical Inc shares are lower today, continuing a downward trend seen since Tuesday's close, with no specific news identified for the decline.

2026. g. 21. jūl. 20:01 UTC

Collegium Pharmaceutical Inc is trading higher amid a broader market rally, with the Pharmaceuticals sector also gaining momentum. No specific news was identified.

2026. g. 20. jūl. 19:41 UTC

News

Collegium Pharmaceutical plans to move its headquarters to Boston in 2027. Shares are lower amid significant declines in the Pharmaceuticals sub-sector.

Salīdzinājums

Cenas izmaiņa

Collegium Pharmaceutical Inc Prognoze

Cenas mērķis

By TipRanks

82.06% augšup

Prognoze 12 mēnešiem

Vidējais 51.25 USD 82.06%

Augstākais 60 USD

Zemākais 43 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Collegium Pharmaceutical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 4 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Collegium Pharmaceutical Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

150 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.